|
Preanalytic |
Analytic |
Postanalytic |
Anatomic Pathology |
Clinical Pathology |
Turnaround Time |
Patient Safety |
Microbiology |
Transfusion Medicine |
Chemistry/ Hematology |
Customer Satisfaction |
Q-PROBES |
Technical Staffing Ratios (QP191) |
✓ |
✓ |
|
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
✓ |
Opioid Drug Testing Stewardship (QP192) |
✓ |
✓ |
✓ |
|
✓ |
✓ |
✓ |
|
|
✓ |
✓ |
Expression Rates in Invasive Breast Carcinoma (QP193) |
|
✓ |
|
✓ |
|
|
✓ |
|
|
|
✓ |
The Impact of Pathologist Review on Peripheral Blood Smears (QP194) |
✓ |
✓ |
|
|
✓ |
✓ |
✓ |
|
|
✓ |
✓ |
Q-TRACKS |
Patient Identification Accuracy (QT1) |
✓ |
|
|
✓ |
✓ |
|
✓ |
|
|
|
✓ |
Blood Culture Contamination (QT2) |
✓ |
✓ |
|
|
✓ |
|
✓ |
✓ |
|
|
✓ |
Laboratory Specimen Acceptability (QT3) |
✓ |
|
|
|
✓ |
|
|
|
|
✓ |
✓ |
In-Date Blood Product Wastage (QT4) |
|
|
✓ |
|
✓ |
|
|
|
✓ |
|
|
Gynecologic Cytology Outcomes:
Biopsy Correlation Performance (QT5) |
✓ |
✓ |
|
✓ |
|
|
✓ |
|
|
|
✓ |
Satisfaction With Outpatient Specimen Collection (QT7) |
✓ |
|
|
|
✓ |
|
✓ |
|
|
|
✓ |
Stat Test Turnaround Time Outliers (QT8) |
|
✓ |
|
|
✓ |
✓ |
✓ |
|
|
✓ |
|
Critical Values Reporting (QT10) |
|
|
✓ |
|
✓ |
|
✓ |
|
|
✓ |
|
Troponin Turnaround Times (QT15) |
✓ |
✓ |
✓ |
|
✓ |
✓ |
✓ |
|
|
✓ |
✓ |
Corrected Results (QT16) |
|
|
✓ |
|
✓ |
|
✓ |
✓ |
✓ |
✓ |
✓ |
Outpatient Order Entry Errors (QT17) |
|
|
|
|
✓ |
|
✓ |
|
|
✓ |
|
*The CAP requires accredited laboratories to have a quality management plan that covers all areas of the laboratory and includes benchmarking key measures of laboratory performance (GEN.13806, GEN.20316, COM.04000). The Joint Commission requires accredited hospitals to regularly collect and analyze performance data (PI.01.01.01, PI.02.01.01). CLIA requires laboratories to monitor, assess, and correct problems identified in preanalytic, analytic, and postanalytic systems (§493.1249, §493.1289, §493.1299).